Klotho Neurosciences Wins BioTech Breakthrough Award for Cell Therapy Innovation.
ByAinvest
Friday, Nov 7, 2025 10:06 am ET1min read
KLTO--
Klotho Neurosciences has been awarded the "Cell Therapy Innovation of the Year" category at the Fifth Annual BioTech Breakthrough Award. The company is developing gene and cell therapies using a patented form of the human Klotho gene to address neurodegenerative and age-related diseases such as ALS, Alzheimer's, and Parkinson's. Klotho's therapies aim to slow, halt, or reverse disease progression and offer durable, disease-modifying benefits for patients with limited treatment options.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet